Interpretations of ‘appropriate’ minority inclusion in clinical research
- 15 February 2004
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (4) , 249-252
- https://doi.org/10.1016/j.amjmed.2003.09.032
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Race, ethnic group, and clinical researchBMJ, 2003
- Molecular Basis of Ethnic Differences in Drug Disposition and ResponseAnnual Review of Pharmacology and Toxicology, 2001
- Multilocus Genotypes, a Tree of Individuals, and Human Evolutionary HistoryAmerican Journal of Human Genetics, 1997
- How the new NIH guidelines on inclusion of women and minorities apply: Efficacy trials, effectiveness trials, and validity.Journal of Consulting and Clinical Psychology, 1996
- Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulationJournal of Clinical Epidemiology, 1996
- Discussion of “inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 — The perspective of NIH clinical trialists”Controlled Clinical Trials, 1995
- Response to “inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 — The perspective of NIH clinical trialists”Controlled Clinical Trials, 1995
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995
- Historical background of changes in FDA policy on the study and evaluation of drugs in womenAcademic Medicine, 1994
- Inclusion of women in clinical researchAcademic Medicine, 1994